Clinical Trial to Evaluate the Safety and Effectiveness of TQB2618 Injection Combined Therapy in Patients With Advanced Esophageal Squamous Cell Carcinoma
Clinical trial NCT05834543 · TERMINATED
Trial details
- NCT number
- NCT05834543
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-26
- Primary completion
- 2024-10-23
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.